NCT01631188

Brief Summary

The study is being done to determine if the Endovent pulmonary catheter kit, used for port access surgery, can be used as a passageway for a pacing wire. The study hypothesis is that the Endovent kit can be used effectively as a passageway for a pacing wire system.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2011

Longer than P75 for not_applicable

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2012

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 29, 2012

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
6 years until next milestone

Results Posted

Study results publicly available

November 16, 2021

Completed
Last Updated

November 16, 2021

Status Verified

November 1, 2021

Enrollment Period

4 years

First QC Date

March 12, 2012

Results QC Date

May 3, 2021

Last Update Submit

November 15, 2021

Conditions

Keywords

Minimally Invasive SurgeryPort Access SurgeryHeartPacingWireMICSCardiac BypassEpicardial pacingpacing catheterpacing wirepacing swanpacing pulmonary catheterPulmonary EndoventCatheterAortic Valve SurgeryEdwards Lifesciences

Outcome Measures

Primary Outcomes (2)

  • Number of Participants Were the Endovent Pacing Wire Were Able to Obtain a Ventricular Sensing Signal

    Heart to begin pacing upon passing the wire through the catheter to the heart. The catheter would be to be able to pace the heart, with 5 or less milliamps, post heart surgery

    Preparing to wean from the cardiopulmonary bypass machine (heart lung machine) until 40 hours post wean.

  • Number of Participants That Required Pacing Who Were Able to be Paced

    To be able to pace the heart post aortic valve replacement surgery

    Preparing to wean from the cardiopulmonary bypass machine (heart lung machine) until 40 hours post wean.

Secondary Outcomes (1)

  • Number of Participants Who Developed Abnormal Blood Pressure or Heart, and/or Arrhythmias Potentially Related to the Pacing Endovent

    Preparing to wean from the cardiopulmonary bypass machine (heart lung machine) until 40 hours post wean.

Study Arms (1)

Aortic Valve Replacement

EXPERIMENTAL

During surgery your doctor will utilize a new technique using surgical equipment that have already been FDA Approved for other indication. The combination of the equipment and technique will be experimental and will be closely evaluated during and after each case.

Procedure: Minimally Invasive Aortic ValveProcedure: Minimally Invasive Aortic Valve SurgeryDevice: Manipulation in OR surgical technique

Interventions

Patients having minimally invasive aortic valve surgery will have a pacing wire placed through the endovent catheter. The anesthesiologist will attempt to pace the ventricle with this wire if needed to wean from bypass.

Aortic Valve Replacement

The Anesthesiologist will advance a pacing wire through the Endovent Catheter under TEE in order to pace the heart when the subject is coming off the Cardiopulmonary bypass machine

Also known as: AVR, Mini AVR, Minimally invasive Port Access Surgery
Aortic Valve Replacement

Endovent and pacing wire when coming off cardiopulmonary bypass

Also known as: AVR, mini avr,
Aortic Valve Replacement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>= 18 years of age patients having aortic valve port access surgery
  • Scheduled for Minimally Invasive Port Access Aortic Valve Study
  • Patient must agree to study participation; understand and sign the written informed consent

You may not qualify if:

  • \< 18 years of age Patients are excluded if they are not having minimaly invasive aortic valve surgery not having aortic valve port access surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Aortic Valve Disease

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Results Point of Contact

Title
Enrique Pantin, MD
Organization
Rutgers University

Study Officials

  • Enrique L Pantin, MD

    Rutgers, The State University of New Jersey

    PRINCIPAL INVESTIGATOR
  • Jonathan Kraidin, MD

    Rutgers, The State University of New Jersey

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Anesthesiology

Study Record Dates

First Submitted

March 12, 2012

First Posted

June 29, 2012

Study Start

December 1, 2011

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

November 16, 2021

Results First Posted

November 16, 2021

Record last verified: 2021-11